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Trichomoniasis is one of themost common acute sexually transmitted curable diseases, and it is disseminatedworldwide generating
more than 170 million cases annually. Trichomonas vaginalis is the parasite that causes trichomoniasis and has the ability to
destroy cell monolayers of the vaginal mucosa in vitro. Sphingomyelinases (SMase) are enzymes that catalyze the hydrolysis of
sphingomyelin into ceramide and phosphorylcholine. Ceramide appears to be a second messenger lipid in programmed apoptosis,
cell differentiation, and cell proliferation. Sphingomyelinase is probably a major source of ceramide in cells. Signal transduction
mediated by ceramide leads cells to produce cytokine induced apoptosis during several inflammatory responses. SMase are also
relevant toxins in several microorganisms. The main objective of this research is to identify SMase activity of T. vaginalis in the
total extract (TE), P30, and S30 subfractions from brooked trophozoites. It was found that these fractions of T. vaginalis have SMase
activity, which comes principally from P30 subfraction and was mainly type C. Enzymatic activity of SMase increased linearly with
time and is pH dependent with two peaks by pH 5.5 and pH 7.5. The addition of manganese to the reaction mixture increased the
SMase activity by 1.97.
1. Introduction
Trichomoniasis is caused by the unicellular flagellated pro-
tozoan parasite named Trichomonas vaginalis which is one
of the most prevalent sexually transmitted diseases. It has
a worldwide distribution, and WHO estimates that more
than 170 million cases are reported each year [1]; of these,
18.5 million come from Latin America [2]. In Mexico, more
than 125,000 new cases are reported annually [3]. T. vaginalis
infects both genders. In men this infection is commonly
asymptomatic; however it may cause urethritis, prostatitis,
cystitis, epididymitis, and infertility. In women the infection
normally causes symptoms of vulvovaginitis and urethritis
with vaginal discharge, irritation, dysuria, and abdominal
pain. Vaginal secretion may also be yellow-green, itchy,
frothy, and foul-smelling [4]. In pregnant women this disease
has been related to premature rupture of amniotic mem-
branes, premature birth, and low birth weight [5]. Patients
with trichomoniasis are more susceptible to develop HIV
seroconversion [6].
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T. vaginalis is pyriform and grows in microaerophilic
conditions when cultured. It has two main stages: flagellated
and trophozoite [7]. To this date, there is no knowledge of
resistant cysts forms [4].T. vaginalis does not havemitochon-
dria, instead it has hydrogenosomes, organelles with noDNA,
formed by three chromatic granules [8]. Energy requirements
are provided by the transformation of glucose to glycerol
and succinate in the cytoplasm, followed by the subsequent
conversion ofmalate to pyruvate, hydrogen, and acetate in the
hydrogenosomes [9–11]. T. vaginalis has the ability to destroy
monolayers of epithelial cells isolated from human vaginal
mucosa in vitro by detaching them, lysing them [12–14], or
by phagocytosis [15, 16]. Engbring and Alderete [17] reported
that T. vaginalis has a high specificity to bind only to mucosal
epithelial cells of the genitourinary tract.This process ismedi-
ated by proteases found in the parasite’s surface. Some authors
have identified and characterized several cysteine proteinases
and adhesins that participate in adhesion and cytotoxicity of
the parasite to the vagina and ectocervix [18, 19].
Although the pathogenic mechanisms of T. vaginalis are
unknown, there are some factors related to its destructive
effect, also its ability to proliferate and damage host cells [20,
21]. At this time, several parasite molecules have been
identified as the cause of damage in cells and tissues of the
host [20, 21]. Several hydrolases have been described in T.
vaginalis; those with low molecular weight may be released
into the cell medium [20]. Some of these molecules partici-
pate in specific cell damage including neuraminidase [22], 𝛽-
N-acetylglucosaminidase (EC 3.2.1.30), 𝛼-mannosidase (EC
3.2.1.24), 𝛽-glucosidase (EC 3.2.1.21), acid phosphatase (EC
3.1.3.2), cysteine proteases [17, 20, 23], and phospholipases
[21]. Also, an additional molecule of membrane attack has
been recently detected in T. vaginalis and called lytic factor,
which is able to destroy cells and nucleate erythrocytes as
well as acting specifically on phosphatidylcholine suggesting
an activity of phospholipase A2. Vargas-Villarreal et al.
[21] demonstrated direct and indirect activities dependent
of hemolytic phospholipase A (A1 and A2) in subcellular
extracts fromT. vaginalis.These activities have been proposed
as responsible for hemolytic and cytolytic effects of T. vagi-
nalis.
Sphingomyelinases (SMase) are enzymes that catalyze the
hydrolysis of sphingomyelin into ceramide and phosphoryl-
choline and are defined as EC 3.1.4.12. They are classified
according to their pH requirements (alkaline, neutral, and
acidic) and of these enzymes themost common are the SMase
type C (SMase-C, EC 3.1.4.12) and SMase type D (SMase-
D, EC 3.1.4.41). Both enzymes degrade sphingomyelin, but
SMAase C produces sphingomyelinase and ceramide phos-
phorylcholine while SMAase D produce choline and phos-
phorylceramide [24].
Enzymes with sphingomyelinase activity have been iden-
tified and proposed as possible virulence factors in other
organisms such as the violin spider venom [25], Clostrid-
ium perfringens [26], Bacillus cereus [23], Staphylococcus
aureus [23], Leptospira interrogans [27], and Neisseria gonor-
rhoeae [28]. This activity is important in physiological and
pathophysiological processes in mammalian cells such as
sphingomyelin digestion in lysosomes [29]. Ceramides are
involved as second messengers in cytokine inducing apopto-
sis [30–32], cell differentiation [33], and in the immune and
inflammatory responses [34].
The main objective of this research was to identify sph-
ingomyelinase activity in the total extract, P30, and S30
subfractions of T. vaginalis.
2. Material and Methods
2.1. Biological Material
2.1.1. Trichomonas vaginalis Strain. Strain GT-15 of T. vagi-
nalis was gently donated to us by Dr. Fernando Anaya-
Vela´zquez from the Experimental Biology Institute, Chem-
istry Faculty, Guanajuato University, Mexico. It was main-
tained under cryopreservation and reseeds three times per
week in our laboratory in PEPHS medium, supplemented
with 10% (v/v) bovine serum and Diamond’s vitamins-Tween
80 mixture [35]. The strain of T. vaginalis remains in three
tubes at a time. The best growth culture was inoculated 5 ×
103 trophozoites/mL in three new tubes with fresh PEHPS
[7, 36, 37]. Trophozoites used in the experiments were grown
in suspension in spinner flasks [7, 21, 38].
2.2. Preparation of Subcellular Fractions. The subcellular
fractions were prepared as described previously [38]. Briefly,
pellet containing trophozoites harvested from the spinner
flasks were suspended in two volumes of Hank’s balanced salt
solution BSS (0.7mMCaCl
2
, 5.5mMGlucose, 120mMNaCl,
5.3mM KCl, 1.7mM MgSo
4
, 1 mM Trizma base, and pH
7.5). The trophozoites were disrupted with an electric motor-
driven Potter-Elvehjem Teflon-glass homogenizer (Bellco,
Glass Inc., NY, USA) [38] and activated at 1000 rpm, rep-
resenting the fraction total extract (TE). This fraction was
separated in two parts; the first 3mL of extract was divided
in 0.5mL aliquots and stored at −70∘C until required. The
remaining TE was centrifuged at 30,000×g during 15min at
4∘C. The resultant supernatant (S30) was stored until being
used. The pellet (P30) was resuspended with 1 volume BSS,
distributed in 200𝜇L aliquots, and stored at −70∘C. Before
the initiation of each experiment, a sufficient numbers of
TE, P30, and S30 aliquots were thawed at room temperature
and diluted with BSS to adjust the proteins concentration,
according to each experiment design.
2.3. Determining Sphingomyelinase Activity. Sphingomyel-
nase activity (SMAase) was determined by radio assay in
soluble and particulate samples. It was previously described
by Vargas-Villarreal et al. [38]. Briefly, substrate was prepared
by mixing 1mL of 100mM Trizma base (pH 7.5) solution,
1mM MgCl
2
, 0.2% of Trito´n X 100, 4mg sphingomyelin,
and 2.5 𝜇Ci [N-methyl-14C]-sphingomyelin ([14C]-sphingo-
myelin [47mCi/mmol]) (PerkinElmer Life and Analytical
Science, Boston, MA, USA), in 1.5mL borosilicate (Bellco,
Glass Inc., Vineland, NJ, USA). The mixture was sonicated
in an Ultratip Labsonic System (Lab-Line Instrument Inc.,
Melrose Park, IL, USA), applying one pulse of 40W for 60 s.
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This substrate preparation was divided into 0.5mL aliquots
and stored in vials at −70∘C until being used.
A 10 𝜇L of assaymixture and 10 𝜇L 2Xmixture containing
several amounts of fractions from T. vaginalis, TE, P30,
or S30 (0–400𝜇g of total protein of each fraction), were
deposited in tubes 7 × 75mm borosilicate (Bellco, Glass
Inc., NY, USA). Tubes were shaken on vortex for 30 s and
incubated at 37∘C for 150min in a moist chamber. After
incubation time, the reaction was stopped by adding 25𝜇L
of 1mg/mL sphingomyelin, 1mg/mL phosphorylcholine, and
1mg/mL choline (Sigma Chemical Co, St Louis, MO, USA)
in 5% trichloroacetic acid in n-butanol. Then the lipids from
each sample containing nondigested sphingomyelin were
separated from the SMase hydrolysis products by thin layer
chromatography (TLC) [38].
2.4. Thin Layer Chromatography. The assay mixtures (45 𝜇L)
were applied on 10 × 10 cm silica gel plates (0.25mm thick,
60-mesh, Merck, Darmstadt, Germany). The plates were
placed separated into a TLC developing tank containing
a mobile phase chloroform/methanol/water (65 : 25 : 4, v/v).
Spots corresponding to choline, phosphorylcholine (origin),
and sphingomyelin (𝑅
𝑓
= 0.29) were developed by exposing
the TLC plates to iodine vapors for 10min [39].
To identify the [14C]-sphingomyelin, [14C]-phosphoryl-
choline, and [14C]-choline spots, their respective relative
migration coefficients (𝑅
𝑓
) were comparedwith those of their
corresponding nonradioactive standards (Sigma). Visualiza-
tion of spots corresponding to [14C]-sphingomyelin, [14C]-
phosphorylcholine, and [14C]-choline was scraped from the
TLC silica gel plates and placed into plastic vials contain-
ing 5mL scintillation liquid (BCS, Biodegradable Counting
Scintillation fluid; Amersham). Radioactivity in each vial
was determined with a 1600 Tri-Carb liquid scintillation
spectrometer (Packard Instrument Company, Inc., Downers
Grover, IL, USA). The instrument was adjusted to work with
unquenched samples with 96% efficiency. One unit of
SMase activity was defined as 1 pmol [14C]-sphingomyelin
hydrolyzed (equivalent to the number of picomoles of [14C]-
phosphorylcholine released) in 1 hr of incubation. Specific
activity was defined as the amount of units of SMase activity
per milligram of total Trichomonas proteins for 1 hr incuba-
tion at 36.5∘C (U SMase/mg/hr).
The type of SMase activity was classified by its cleav-
age site. Trichomonas preparations (TE, P30, and S30;
400𝜇g/mL) were assayed (at pH 7.5), using the method of
sphingomyelinase chromatography bidirectional thin plate,
When using protease inhibitors sphingomyelinase activity
increases tenfold. The radioactive hydrolysis products were
identified by comparing their final locationwith those of their
respective standard [23].
The first mobile phase contained methanol/water (25 : 25
v/v) while chloroform/methanol/water (65 : 25 : 4 v/v) was
used as the second mobile phase [38].
All determinations were performed three times in tripli-
cate andwere presented as themean±1 specific activity of the
SMase (SMase U/mg total protein/hr) was arbitrarily defined
as 1U = 1DPM SMAase.
2.5. Effects of Inhibitors, Incubation Time, Dose of Proteins,
pH, and Dissolvent Cations on Trichomonas SMase Activity.
The effect of inhibitors on SMase activity was measured
from TE, P30, or S30 fractions in the presence of sodium
salt p-chloromercuribenzoate, a protease inhibitor, in a final
concentration of 0.1mM in all fractions [40, 41]. Incubation
time was determined by incubation of TE, P30, or S30
assay samples (each containing 400 𝜇g of total protein) for
0–150min. Dose response curves were obtained using 0–
400 𝜇g of P30 total protein. Finally, the effect of pH was
analyzed by adjusting the pH values (2–10) with appropriate
concentration of glycine-HCl (pH 2–2.5), sodium acetate (pH
3–6), or Trizma base (pH 7–10).The requirement for divalent
cations was analyzed by adding 1mM or 10mM of MgCl
2
,
MnCl
2
, CoCl
2
, CaCl
2
, HgCl
2
, and ZnSO
4
or 1 or 10mM
EDTA and 10 𝜇L to the P30 fraction. Activity was determined
as described previously.
2.6. Total Protein Quantification. The concentration of pro-
teins was calculated in biological samples by the method of
Lowry et al. [42].
2.7. Statistical Analysis. All the experiments were performed
three times in triplicate (𝑛 = 9). Plots of incubation time and
dose were analyzed by linear regression, and the results were
compared by ANOVA for data normally distributed.
3. Results
3.1. Detection of Sphingomyelinase Activity in Total Extracts
(TE), P30, and S30 Fractions of T. vaginalis. Trichomonas
extracts have SMase activity andwere able to hydrolyze [14C]-
sphingomyelin. All fractions (TE, P30, and S30) have this
activity. But it was found that sphingomyelinase activity was
higher in TE (2.57U/mg/hr) and P30 (2.43U/mg/hr), and
S30 was less active (Figure 1). When inhibitors proteases as
the p-chloromercuribenzoate were used, it was found that
sphingomyelinase activity increased in all fractions by a factor
of 10 times (Figure 1).
3.2. Identification of the Type of Sphingomyelinase-C and an
Unidentified ESase Activity Present in TE and P30 of T. vagi-
nalis. When sphingomyelinase activity was determined in
P30 and TE fractions it was found that virtually all the
[14C]-phosphorylcholine activities corresponded to 96% and
4% to [14C]-choline (Figure 2). It was confirmed that the
sphingomyelinase activity of T. vaginalis is a type C. In
addition, small but reproducible quantities of [14C]-choline
were detected, indicating the presence of other esterase
activity (ESase activity) in TE and P30 fractions (Figure 2).
3.3. Concentration and Time-Dependent SMase-C Activity
from P30. P30 shows a time-dependent SMase C activity; a
graphical representation of this activity can be observed in
Figure 3.
It was found in the dose response curve that the radioac-
tivity in the spots corresponding to [14C]-phosphorylcholine
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Figure 1: Subcellular distribution of T. vaginalis SMase activity.
Shadowed and clear bars correspond to specific activity SMase
(U SMase/mg/hr) assays with absence or presence of inhibitor
p-chloromercuribenzoate, respectively. The total extract (TE) or
the subcellular fractions P30 or S30 obtained from T. vaginalis
trophozoites were evaluated. [14C]-sphingomyelin was used as the
substrate for all assays. The products of the hydrolysis were [14C]-
phosphorylcholine or [14C]-choline. Each bar represents themean±
SE from three independent experiments performed in triplicates.
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Figure 2: SMase-C activity and unidentified esterase activity in
TE and P30 fractions. Shadowed and clear bars correspond to
specific activity of SMase-C or esterase activity from TE and P30
fractions from T. vaginalis trophozoites, respectively. The hydrolysis
products were [14C]-phosphorylcholine for SMase-C activity and
[14C]-choline for esterase activity. Each bar represents the mean ±
SE from three independent experiments performed in triplicates.
steadily increased with increasing concentrations of the P30
fraction from 0 to 400 ug of total protein (Figure 4), showing
low proportionality concentrations (less than 100𝜇g).
3.4. Effect of pH on SMase Activity of P30. Figure 5 shows
that 400 𝜇g of the total protein of the membrane-associated
P30 fraction incubated for 150min at 37∘C has two peaks of
activity, one at pH 5.5 and the other at pH 7.5.The peak at pH
7.5 corresponds to the highest SMase specific activity and was
1.9 times higher than the acidic activity showed at pH 5.
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Figure 3: Time-curse of SMase activity from the P30 subcellular
fraction. Fractions of P30 containing 400 𝜇g of proteins total by
assay were tested by several incubation times (0–150min). Then
[14C]-phosphorylcholine released was measured. Symbols corre-
spond to mean ± SE of nine determinations of three independent
experiments.
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Figure 4: Dose dependence of membrane-associated SMase-C
activity. Several protein total concentrations (0–400𝜇g) of P30
incubated for 150min at pH 7.5 were tested. Then [14C]-phos-
phorylcholine released was measured. Symbols correspond to
mean ± SE of nine determinations of three independent experi-
ments.
3.5. Effect of Cations on SMAase Activity of P30. Several
cations were tested as described in Table 1; the mixtures were
treatedwith EDTA,MgCl
2
,MnCl
2
, CoCl
2
, CaCl
2
, HgCl
2
, and
ZnSO
4
. It was observed that the cation which produced a
maximum stimulation effect of Mn2+ was 1.97 times more
than the control without cations followed by Mg2+ and Co2+
with results 70 and 84% higher than the control, respectively.
Furthermore the effect with EDTA was 0.13 times less than
the one which occurred with the control. However, CaCl
2
,
HgCl
2
, and ZnSO
4
cause inhibition of SMase activity by 40
to 93% (see Table 1).
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Table 1: Normalized SMAase activity modulated by addition of
cations and EDTA into assays.
Trichomonas vaginalis GT-15 P30 fraction
Cations Normalized specific activity
Any 1
EDTA 0.13
MgCl2 1.71
MnCl2 1.97
CoCl2 1.84
CaCl2 0.5
HgCl2 0.171
ZnSO4 0.609
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Figure 5: Effect of pH on membrane-associated SMase-C activity.
Fractions of P30 containing 400𝜇g of proteins total by assay were
tested by several pH values (2–10). Then [14C]-phosphorylcholine
released was measured. Symbols correspond to mean ± SE of nine
determinations of three independent experiments.
4. Discussion
The ability to synthesize toxic substances offers some advan-
tages to several organisms to fend off predators or when cap-
turing a prey. These substances are commonly called poisons
and are secreted by glands or buccal organs and in some
other cases they are secreted through the skin [43]. Similarly,
many microorganisms can produce this type of substances
that act as pathogenetic factors favoring the invasion of
the host. These substances can cause serious disruption to
the host’s health [9, 44]. Poisons are usually proteins; the
best known are the lipases, phosphatases, hyaluronidases,
phospholipases, and sphingomyelinases. Phospholipases and
sphingomyelinases are the most studied poisons to date and
are recognized to be involved in invasion processes, activa-
tion of second messengers, and cytopathogenic mechanisms
present in many species of microbes [45].
We have demonstrated the presence of phospholipases
in Trichomonas [21], amoeba [46], and giardia [47]. But the
presence of sphingomyelinases has not been described in T.
vaginalis. This study was conducted in order to identify and
isolate the production of sphingomyelinase from T. vaginalis
and thereby build a base of knowledge of the physiopathology
of this microorganism that causes serious damage to those
affected, such as urethritis, vulvovaginitis, infertility, preterm
childbirth, and predisposition to get HIV [6].
T. vaginalis is a protozoan with high specificity to bind
only to the epithelial cells of the mucosa of the urogenital
tract. This process is mediated by proteases found in the
parasitic surface and which are decisive in the establishment
of infection and participate in pathogenicity. Because once
implanted in the vagina the microorganism is able to obtain
nutrients from bacteria and leukocytes in the vaginal or
urethral cavity, and it is also capable of destroying the host
cells [17].
For this to happen, it is necessary first for an invasion to
break the integrity of the membranes of the host so the sugar
residues present on the surface of the parasite can participate,
in particular alpha-D-mannose and N-acetylglucosamine,
which are involved in the etching process of T. vaginalis [48].
This work suggests that the production of sphingomyelinase
helps break the membrane components of the host cell. The
in vitro cytopathic effect of T. vaginalis in MDCK epithelial
cells has been intensively studied; these parasite trophozoites
produce severe damage to the cell monolayer in 30 minutes
and a rapid decrease of the transepithelial resistance [13, 14].
Several researchers have demonstrated virulence factors,
proteinases, and adhesins, such as (CP30) which is a 30 kDa
proteinase required for parasite adhesion to the target cell
[49]: a cysteine proteinase of 65 kDa (CP65) and protein
of 120 kDa inducible by high concentrations of iron called
AP120 produced by T. vaginalis are thought to have cytotoxic
activity [50]. Although the pathophysiological mechanisms
of T. vaginalis are not completely defined, they are now
recognized as important virulence factor dependent cell-cell
contacts and several secreted factors that cause cell damage
as consequence of the symptoms of the patients [20, 21].
GT-15 strain of T. vaginalis was selected for being one of
the strains that produce higher crop yields [7] and because it
was detected and quantified for hemolytic activity of cytolytic
phospholipase A in direct and indirect assays in studies
realized previously [38].
In this work, the mass culture of T. vaginalis was frac-
tionated to identify sphingomyelinase activity present in the
total extract (TE) and the subcellular fractions P30 and
S30 (Figure 2). The fractions were obtained by mechanical
homogenization to preserve as far as possible the subcellular
compartmentalization and prevent protein denaturalization
caused by freeze-thaw cycles [51, 52]. Bovine serum was not
included in the assays to avoid the presence of undefined
factors in the reaction mixtures that can interfere with the
activity of sphingomyelinase [53].
The activity of sphingomyelinase was determined using
the previously developed assay for phospholipase activity
and published by Vargas-Villarreal et al. [46], adapted for
sphingomyelinase activity detector with modifications to the
reaction mixture so as not to exceed 60 𝜇L. This amendment
would grant two major advantages to this new method:
(a) it is possible to analyze a greater number of samples
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simultaneously, as it requires fewer radioactivity than other
methods [54] and (b) save a considerable amount of reagents.
Results showed the presence of sphingomyelinase activity
in the totality of the extracts of T. vaginalis and principally
in the P30 fraction. As P30 is a particulate fraction [55], it is
likely that such activity is present in the plasma membrane of
this protozoan.
To discriminate against that type of activity C or D sph-
ingomyelinase is present in TE and P30 fractions. Was used
as substrate [14C]-sphingomyelin, whereas if after incubation
with P30 and TE the radioactivity was located on the chro-
matographic spot corresponding to [14C]-phosphorylcholine
but not in the [14C]-choline, then enzymes sphingomyelinase
would be of type C. Sphingomyelinase type C activity was
confirmed when both fractions showed a remarkable activ-
ity in the spots corresponding to [14C]-phosphorylcholine,
and then these fractions subjected them to a bidirectional
chromatography. These results undoubtedly confirm that the
sphingomyelinase activity present in T. vaginalis is of type
C. It was demonstrated that from all of the degradation
products of [14C]-sphingomyelin 4% were [14C]-choline. It
corresponds with type D SMase activity, probably caused by
unidentified esterase.
In previous studies trichomonas [56] have been shown
to have protease activity. Since trichomonas extracts may
contain proteases, a protease inhibitor was used for an
activity free of inhibitory effects from these enzymes. An
inhibitor of proteases that does not interfere with the activity
of sphingomyelinase was used in this assay [40, 41]. The
outcome shows an increase more than 10 times in the SMase
activity (Figure 1). It was shown that the proteases were
affecting sphingomyelinase activity in all fractions.
The effect of pH on the activity of sphingomyelinase
in the fraction P30 presents two peaks, one at pH 5.5
and other at pH 7.5; the latter was almost twice as high
(Figure 5). This concludes that P30 has at least two isoforms
of sphingomyelinase. Previous studies state that the first
sphingomyelinase activity acting on pH 5.5 has as preferred
cofactor Zn; the second isoform acting at a basic pH of 7.5
requires Mg as cofactor. For now, we characterize the activity
of Mg as a dependent alkaline sphingomyelinase.
It was also demonstrated that other cofactors such as
manganese and cobalt can stimulate between 71 to 97%
of sphingomyelinase activities at pH 7.5. Besides EDTA,
calcium, mercury, and zinc inhibit this activity between 39
and 87% (Table 1).
5. Conclusions
The main contribution of this work is the identification of
SMase activity in the total extract, P30, and S30 fractions of T.
vaginalis.This activity is principally of type C and ismainly in
the subfraction P30. It showed two peaks of activity at pH 5.5
and 7.5.The activity at pH 7.5 can be increased using cofactors
principally Mg.
For the future it is necessary to investigate type D SMase
activity to determine the presence of esterase in the extracts
and subfractions from T. vaginalis, as well as study SMase
fraction that is active at pH 5.5.
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